Use of recombinant human erythropoietin for the treatment of anemia in obstetrics and gynecology. Evaluation of the value of this treatment as an alternative to blood transfusion;Impiego dell'eritropoietina umana ricombinante in stati anemici di interesse ostetrico-ginecologico. Valutazione dell'utilità di tale trattamento in alternativa all'emotrasfusione

Minerva Ginecologica

Volumn 48, Issue 3, 1996, Pages 115-118

  Delzanno, G ^a,c   Falcone, M ^a   Gaudiano, L ^a   Bertinetti, G ^b   Demarchi, A ^b   Paoletti, R ^b  

^a Ospedale San Biagio   (Italy)

^b Ospedale Civile   (Italy)

^c NONE   (Italy)

Author keywords

Alternative therapy; Anemia; Recombinant human erythropoietin

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW; CLINICAL ARTICLE; DRUG TOLERANCE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; INTERMETHOD COMPARISON; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ANEMIA; BLOOD TRANSFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; FEMALE; FERROUS COMPOUNDS; FOLIC ACID; GENITAL DISEASES, FEMALE; HUMANS; PREGNANCY; PUERPERAL DISORDERS; VITAMIN B 12;

EID: 0029920316     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Coulombel L, Drueke T, Kreis H, Nissen-Druey C, Marty M. Therapeutic use of recombinant hematopoietic growth factors. Nouv Rev Fr Hematol 1989;31.93-101.
2. Spivak JL. Erythrpoietin. Blood Reviews 1989,3.130-5
3. Adamson JW Erythropoietin, in vitro and in vivo studies of the regulation of erythropoiesis. Schweiz Med Wschr 1988;118:1501-6.
4. Zanjani ED, Ascensao JL Erythropoietin Transfusion 1989,29:46-57.
5. Van Stone JC. Who should receive recombinant human erythropoietin? Semin Nephrol 1989;9(Suppl 2).3-7
6. McCaffery P, Fraser JK, Fu-Kuen Lin, Berridge MV. Subnnit structure of the erythropoietin receptor. J Biol Chem 1989,264:10507-12.
7. Miladenivic J. Kay N. Erythropoietin induces rapid increase in intracellular free calcium in human bone marrow cells. J Lab Clin Med 1988;112 23-7
8. Winearls CG. Treatment of the anaemia of cronic renal failure with recombinant human erythropoietin. Drugs 1989;38:342-5.
9. Stivelman JC. Resistence to recombinant human eruthropoietin therapy: a real clinical entity? Semin Nefrol 1989;9(Suppl 2):8-11.
10. Graf H, Barnas U, Loibl U, Mcisl F, Watzinger U, Mayer G. Subcutaneous versus intravenous administratio nof recombinant erythropoietin a prospective study of effectiveness and side efects. Atti 26th Congress of the EDTA-ERA, 11-15 June 1989, Goteborg.
11. Rudnik S, Abels R, Danna R, Milak D. Correzioen con eritropoietina dell'anemia cronica nei pazienti affetti da neoplasie. Proceedings from Am Society of Clinical Oncol Meeting, Washington, May 1990.
12. Henry D, Keller A, Kugler J et al. Trattamento con eritropoietina dell'anemia secondaria a cisplatino in pazienti affette da neoplasie. Proocedings from am Society of Clinical Oncol Meeing, Washington, May 1990.
13. Ponticelli C, Casati S. Correction of anaemia with recombinant human eruthropoietin. Nephron 1989;52:201-8